Leptin, Ghrelin, and Proinflammatory Cytokines: Compounds with Nutritional Impact in Chronic Kidney Disease?

Advances in Renal Replacement Therapy

Volumn 10, Issue 4, 2003, Pages 332-345

  Stenvinkel, Peter ^a   Pecoits Filho, Roberto ^a   Lindholm, Bengt ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ghrelin; Inflammation; Leptin; Malnutrition; Proinflammatory cytokines

Indexed keywords

ACRYLAMIDE; ALBUMIN; CARCINOGEN; CYTOKINE; ERYTHROPOIETIN; GHRELIN; GLUCOCORTICOID; INDOMETACIN; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR; MEGESTROL ACETATE; MESSENGER RNA; NEUROPEPTIDE Y; PENTOXIFYLLINE; PEPTIDE HORMONE; PREDNISOLONE; SEX HORMONE; STEROID HORMONE; TETRAHYDROCANNABINOL; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; UREMIC TOXIN;

ADRENALECTOMY; ALKALOSIS; ANGIOGENESIS; ANOREXIA; BLOOD VESSEL CALCIFICATION; BODY FAT; BODY WEIGHT; BONE MARROW; CACHEXIA; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; ENERGY EXPENDITURE; ERYTHROPOIESIS; FOOD INTAKE; GENE DELETION; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMODIALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERINSULINEMIA; HYPOALBUMINEMIA; HYPOTHALAMUS; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN RELEASE; INSULIN RESISTANCE; KIDNEY CLEARANCE; MALNUTRITION; NEPHRECTOMY; NUTRITION; OBESITY; OVARY; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVIEW; STOMACH ACID; STOMACH ACID SECRETION; STOMACH MOTILITY; T LYMPHOCYTE; UREMIA;

EID: 0348048495     PISSN: 10734449     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.arrt.2003.08.009     Document Type: Article

References (128)

1. Bergström J, Lindholm B: Malnutrition, cardiac disease, and mortality: An integrated point of view. Am J Kidney Dis 32:834-841, 1998
2. Stenvinkel P, Heimburger O, Lindholm B, et al: Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15:953-960, 2000
3. Zimmermann J, Herrlinger S, Pruy A, et al: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
4. Bologa RM, Levine DM, Parker TS, et al: Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107-114, 1998
5. Kimmel PL, Phillips TM, Simmens SJ, et al: Immunological function and survival in hemodialysis patients. Kidney Int 54:236-244, 1998
6. Zhang Y, Proenca R, Maffei M, et al: Positional cloning of the mouse gene and its human homolouge. Nature 372:425-432, 1994
7. Lönnqvist F, Arner P, Nordfors L, et al: Overexpression of the obese (ob) gene in human subjects. Nature Med 1:950-953, 1995
8. Hamilton BS, Paglia D, Kwan AYM, et al: Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Med 1:953-956, 1995
9. Maffei M, Stoffel M, Barone M, et al: Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes 45:679-682, 1996
10. Montague CT, Farooqi IS, Whitehead JP, et al: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908, 1997
11. Farooqi IS, Matarese G, Lord GM, et al: Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093-1103, 2002
12. Saladin R, DeVos P, Guerre Millo M, et al: Transient increase in obese gene expression after food intake or insulin administration. Nature 377:527-529, 1995
13. Friedman JE, Ferrara CM, Aulak KS, et al: Exercise training down-regulates ob gene expression in the genetically obese SHHF/Mcc-fa(cp) rat. Horm Metab Res 29:214-219, 1997
14. Ostlund RE, Yang JW, KLein S, et al: Relation between plasma leptin concentrations and body fat, diet, age and metabolic covariates. J Clin Endocrinol Metab 81:3909-3913, 1996
15. Heimbürger O, Lönnqvist F, Danielsson A, et al: Serum immunoreactive leptin concentrations and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 8:1423-1430, 1997
16. Yoneda N, Saito S, Kimura M, et al: The influence of ovariectomy on ob gene expression in rats. Horm Metab Res 30:263-265, 1998
17. Rosenbaum M, Nicolson M, Hirsch J, et al: Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 81:3424-3427, 1996
18. Tan JT, Patel BK, Kaplan LM, et al: Regulation of leptin expression and secretion by corticosteroids and insulin. Implications for body weight. Endocrine 8:85-92, 1998
19. MacDougald OA, Hwang C-S, Fan H, et al: Regulated expression of the obese gene product (leptin) in white adipose tissue and 3t3-L1 adipocytes. Proc Natl Acad Sci U S A 92:9034-9037, 1995
20. Halleux CM, Servais I, Reul BA, et al: Multihormonal control of ob gene expression and leptin secretion from cultured human visceral adipose tissue: Increased responsiveness to glucocorticoids in obesity. J Clin Endocrinol Metab 83:902-910, 1998
21. Kolaczynski JW, Nyce MR, Considine RV, et al: Acute and chronic effect of insulin on leptin production in humans. Diabetes 45:699-701, 1996
22. Bruun JM, Pedersen SB, Kristensen K, et al: Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol 190:91-99, 2002
23. Kirchgessner TG, Uysal KT, Wiesbrock SM, et al: Tumour necrosis factor-α contributes to obesity-related hyperleptinameia by regulating leptin release from adipocytes. J Clin Invest 100:2777-2782, 1997
24. Medina EA, Erickson KL, Stanhope KL, et al: Evidence that tumor necrosis factor-alpha-induced hyperinsulinemia prevents decreases of circulating leptin during fasting in rats. Metabolism 51:1104-1110, 2002
25. Berkowitz DE, Brown D, Lee KM, et al: Endotoxin-induced alteration in the expression of leptin and b3-adrenergic receptor in adipose tissue. Am J Physiol 37:E992-E997, 1998
26. Grunfeld C, Zhao C, Fuller J, et al: Endotoxin and cytokines induce expression of leptin, the ob gene product in hamsters. A role for leptin in the anorexia of infection. J Clin Invest 97:2152-2157, 1996
27. Sarraf P, Frederich RC, Turner EM, et al: Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 185:171-175, 1997
28. Voegeling S, Fantuzzi G: Regulation of free and bound leptin and soluble leptin receptors during inflammation in mice. Cytokine 14:97-103, 2001
29. Lord GM, Matarase G, Howsrd JK, et al: Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukocy Biol 72:330-338, 2002
30. Zumbach MS, Boehme MW, Wahl P, et al: Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrin Metab 82:4080-4082, 1997
31. Mantzoros CS, Moschos S, Avramopoulos I, et al: Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans. J Clin Endocrinol Metab 82:3408-3413, 1997
32. Janik JE, Curti BD, Considine RV, et al: Interleukin 1 alpha increases serum leptin concentrations in humans. J Clin Endocrin Metab 82:3084-3086, 1997
33. Nordfors L, Lönnqvist F, Heimbürger O, et al: Low leptin gene expression and hyperleptinaemia in chronic renal failure. Kidney Int 54:1267-1275, 1998
34. Pecoits-Filho R, Nordfors L, Heimbürger O, et al: Soluble leptin receptors and serum leptin in end-stage renal disease: Relationship with inflammation and body composition. Eur J Clin Invest 32:811-817, 2002
35. Fouque D, Combarnous F, Sereni L, et al: Leptin is a positive acute phase protein in hemodialysis. J Am Soc Nephrol 12:355A, 2001 (abstr)
36. Don BR, Rosales LM, Levine NW, et al: Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int 59:1114-1120, 2001
37. Tartaglia LA, Dembski M, Weng X, et al: Identification and expression cloning of a leptin receptor, Ob-R. Cell 83:1263-1271, 1995
38. Liu C, Liu XJ, Barry G, et al: Expression and characterization of a putative high affinity human soluble leptin receptor. Endocrinology 138:3548-3554, 1997
39. Lee G-H, Proenca R, Montez JM, et al: Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635, 1996
40. Widjaja A, Kielstein JT, Horn R, et al: Free serum leptin but not bound leptin concentrations are elevated in patients with end-stage renal disease. Nephrol Dial Transplant 15:846-850, 2000
41. Cioffi JA, Shafer AW, Zupancic TJ, et al: Novel B219/OB receptor isoforms: Possible role of leptin in hematopoesis and reproduction. Nat Med 2:585-589, 1996
42. Serradeil-Le Gal C, Raufaste D, Brossard G, et al: Characterization and localisation of leptin receptors in the rat kidney. FEBS Letters 404:185-191, 1997
43. Haalas JL, Gajiwala KS, Maffei M, et al: Weight-reduction effects of the plasma protein encoded by the obese gene. Science 269:543-546, 1995
44. Schwartz MW, Seeley RJ, Campfield LA, et al: Identification of targets of leptin action in rat hypothalamus. J Clin Invest 98:1101-1106, 1996
45. Fan W, Boston BA, Kesterson RA, et al: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165-168, 1997
46. Nonogaki K, Strack AM, Dallman MF, et al: Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2c receptor gene. Nat Med 4:1152-1156, 1998
47. Ravussin E, Prately RE, Maffei M, et al: Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med 3:238-240, 1997
48. Maffei M, Halaas J, Ravussin E, et al: Leptin levels in human and rodent: Measurement of plasma leptin and obRNA in obese and weight-reduced subjects. Nat Med 1:1155-1161, 1995
49. Golden PL, Maccagnan TJ, Pardridge WM: Human-blood-brain barrier leptin receptor. J Clin Invest 99: 14-18, 1997
50. Caro J, Kolazcynski JW, Nyce MR, et al: Decreased cerebrospinal fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 348: 159-161, 1996
51. Yamauchi M, Sugimotot T, Yamaguchi T, et al: Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinology 55:341-347, 2001
52. Ducy P, Amling M, Takeda S, et al: Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100:197-207, 2000
53. Ruhl CE, Everhart JE: Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 17:1896-1903, 2002
54. Rodriguez-Carmona A, Perez Fontan M, Cordio F, et al: Hyperleptinemia is not correlated with markers of protein malnutrition in chronic renal failure. A cross-sectional study in predialysis, peritoneal dialysis and hemodialysis patients. Nephron 86:274-280, 2000
55. Dagogo-Jack S, Ovalle F, Geary B, et al: Hyperleptinaemia in patients with end-stage renal disease treated by peritoneal dialysis. Perit Dial Int 18:34-40, 1998
56. Koo JR, Pak KY, Kim KH, et al: The relationship between plasma leptin and nutritional status in chronic hemodialysis patients. J Korean Med Sci 14:546-551, 1999
57. Young GA, Woodrow G, Kendall S, et al: Increased plasma leptin/fat ratio in patients with chronic renal failure: A cause of malnutrition? Nephrol Dial Transplant 12:2318-2323, 1997
58. Daschner M, Tönshoff B, Blum WF, et al: Inappropriate elevation of serum leptin levels in children with chronic renal failure. J Am Soc Nephrol 9:1074-1079, 1998
59. Stenvinkel P, Lindholm B, Lönnqvist F, et al: Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 11:1303-1309, 2000
60. Dunbar JC, Hu Y, Lu H: Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 46:2040-2043, 1997
61. Shek E, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension 31:409-414, 1998
62. Jackson EK, Li P: Human leptin has natriuretic activity in rat. Am J Physiol 272:F333-F338, 1997
63. Stenvinkel P: Leptin and blood pressure-Is there a link? Nephrol Dial Transpl 15:1115-1117, 2000
64. Wallace AM, McMahon AD, Packard CJ, et al: Plasma leptin and the risk of cardiovascular disease in the west Scotland coronary prevetion study (WOSCOPS). Circulation 104:3052-3056, 2001
65. Sierra-Honigmann MR, Nath AK, Murakami C, et al: Biological action of leptin as an angiogenic factor. Science 281:1683-1686, 1998
66. Parhami F, Tintut Y, Ballard A, et al: Leptin enhances calcification of vascular cells: Artery wall as a target of leptin. Circ Res 88:954-960, 2001
67. Bouloumie A, Marumo T, Lafontan M, et al: Leptin induces oxidative stress in human endothelial cells. FASEB J 13:1231-1238, 1999
68. Cohen B, Novick D, Rubinstein M: Modulation of insulin activities by leptin. Science 274:1185-1188, 1996
69. Emilsson V, Liu Y-L, Cawthorne MA, et al: Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 46:313-316, 1997
70. Kulkarni RN, Wang Z-L, Wang R-M, et al: Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 100:2729-2736, 1997
71. Gainsford T, Willson TA, Metcalf D, et al: Leptin can induce proliferation, differentiation and functional activation of hemopoietic cells. Proc Natl Acad Sci U S A 93:14564-14568, 1996
72. Laharrague P, Larrouy D, Fontanilles A-M, et al: High expression of leptin by human bone marrow adipocytes in primary culture. FASEB J 12:747-752, 1998
73. Stenvinkel P, Heimbürger O, Lönnqvist F, et al: Does the ob gene product leptin stimulate erythropoiesis in patients with chronic renal failure? Kidney Int 53:1430-1431, 1998
74. Sharma K, Considine RV, Beckie M, et al: Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients. Kidney Int 51:1980-1985, 1997
75. Cumin F, Baum HP, Levens N: Leptin is cleared from the circulation primarily by the kidney. Int J Obes 20:1120-1126, 1996
76. Kokot F, Adamczak M, Wiecek A: Plasma leptin concentration in kidney transplant patients at the early posttransplant period. Nephrol Dial Transplant 13:2276-2280, 1998
77. Garibotti G, Russo R, Franceschini R, et al: Inter-organ leptin exchange in humans. Biochem Biophys Res Commun 247:504-509, 1998
78. Swierczynski J, Korczynska J, Szolkiewicz M, et al: Low leptin mRNA level in adipose tissue and normoleptinemia in experimental chronic renal failure. Exp Nephrol 9:54-59, 2001
79. Stenvinkel P, Heimbürger O, Lönnqvist F: Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant 12: 1321-1325, 1997
80. Iglesias P, Diez JJ, Fernandez-Reyes MJ, et al: Effects of short-term recombinant human growth hormone therapy on plasma leptin concentrations in dialysis patients. Nephrol Dial Transplant 17:260-264, 2002
81. Fouque D, Juillard L, Lasne Y, et al: Acute leptin regulation in end-stage renal failure: The role of growth hormone and IGF-1. Kidney Int 54:932-937, 1998
82. Teta D, Bevington A, Brown J, et al: Effects of acidosis on leptin secretion from 3T3-L1 adipocytes and on serum leptin in the uraemic rat. Clin Sci 97:363-368, 1999
83. Zheng F, Qiu X, Yin S, et al: Changes in serum leptin levels in chronic renal failure patients with metabolic acidosis. J Renal Nutr 11:207-211, 2001
84. Ariyasu H, Takaya K, Tagami T, et al: Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 86:4753-4758, 2001
85. Yoshimoto A, Mori K, Sugawara A, et al: Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 13:2748-2752, 2002
86. Takaya K, Ariyasu H, Kanamoto N, et al: Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908-4911, 2000
87. Asakawa A, Inui A, Kaga T, et al: Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120: 337-345, 2001
88. Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature 407:908-913, 2000
89. Cummings DE, Purnell JQ, Frayo RS, et al: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719, 2001
90. Kimmel PL, Phillips TM, Simmens SJ, et al: Immunologic function and survival in hemodialysis patients. Kidney Int 54:236-244, 1998
91. Stenvinkel P, Heimburger O, Paultre F, et al: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911, 1999
92. Qureshi AR, Alvestrand A, Danielsson A, et al: Factors predicting malnutrition in hemodialysis patients: a cross- sectional study. Kidney Int 53:773-782, 1998
93. Yeun JY, Levine RA, Mantadilok V, et al: C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35: 469-476, 2000
94. Yeun JY, Kaysen GA: Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin and peritoneal dialysis patients. Am J Kidney Dis 30:923-927, 1997
95. Yeh SS, Schuster MW: Geriatric cachexia: The role of cytokines. Am J Clin Nutr 70:183-197, 1999
96. Parfrey PS, Foley RN, Harnett JD, et al: Outcome and risk factors for left ventricular disorders in chronic uremia. Nephrol Dial Transplant 11:1277-1285, 1996
97. Levine B, Kalman J, Mayer L, et al: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236-241, 1990
98. Pecoits-Filho R, Lindholm B, Stenvinkel P: The malnutrition, inflammation, and atherosclerosis (MIA) syndrome-The heart of the matter. Nephrol Dial Transplant 17:28-31, 2002 (suppl)
99. Kaizu Y, Kimura M, Yoneyama T, et al: Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 31:93-100, 1998
100. Keys A, Brozek J, Henschel A, et al: The biology of human starvation. The University of Minnesota Press, Minneapolis, MN, 1950
101. Smith G, Robinsson PH, Fleck A: Serum albumin distribution in early treated anorexia nervosa. Nutrition 12:677-684, 1996
102. Bistrian B, Sherman M, Blackburn G, et al: Cellular immunity in adult marasmus. Arch Intern Med 137: 1408-1411, 1977
103. Lunn P, Austin S: Dietary manipulation of plasma albumin concentrations. J Nutr 113:1791-1801, 1983
104. Heimbürger O, Qureshi AR, Blaner WS, et al: Hand-grip muscle strength, lean body mass and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis 36:1213-1225, 2000
105. Kotler DP: Cachexia. Ann Intern Med 133:622-634, 2000
106. King AJ, Kehayias JJ, Roubenoff R, et al: Cytokine production and nutritional status in hemodialysis patients. Int J Artif Org 21:4-11, 1998
107. Plata-Salamán CR: Cytokines and anorexia: A brief overview. Semin Oncol 25:64-72, 1998
108. Kotler DP: Cachexia. Ann Intern Med 133:622-634, 2000
109. Kaibara A, Moshyedi A, Auffenberg T, et al: Leptin produces anorexia and weight loss without inducing an acute phase response or protein wasting. Am J Physiol 43:R1518-R1525, 1998
110. Langhans W, Hrupka B: Interleukins and tumor necrosis factor as inhibitors of food intake. Neuropeptides 33:415-424, 1999
111. Espinosa M, Aguilera A, Auxiliarda BM, et al: Tumour necrosis factor alpha as uremic toxin: Correlation with neuropathy, left ventricular hypertrophy, anemia, and hypertriglyceridemia in peritoneal dialysis patients. Adv Perit Dial 15:82-86, 1999
112. Tracey KJ, Morgello S, Koplin B, et al: Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J Clin Invest 86:2014-2024, 1990
113. Konsman JP, Dantzer R: How the immune and nervous systems interact during disease-associated anorexia. Nutrition 17:664-668, 2001
114. Wallenius V, Wallenius K, Ahren B, et al: Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75-79, 2002
115. Aguilera A, Codoceo R, Selgas R, et al: Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients. Their relationship with nutritional parameters. Nephrol Dial Transplant 13:1476-1483, 1998
116. Suto G, Kiraly A, Plourde V, et al: Intravenous interleukin-1-beta-induced inhibition of gastric emptying: Involvement of central corticotrophin-releasing factor and prostaglandin pathways in rats. Digestion 57:135-140, 1996
117. Senn JJ, Klover PJ, Nowak IA, et al: Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51:3391-3399, 2002
118. Divino Filho JC, Barany P, Stehle P, et al: Free amino-acid levels simultaneously collected in plasma, muscle, and erythrocytes of uraemic patients. Nephrol Dial Transplant 12:2339-2348, 1997
119. Guttridge DC, Mayo MW, Madrid LV, et al: NF-κB-induced loss of MyoD messenger RNA: Possible role in muscle decay and cachexia. Science 289:2363-2365, 2000
120. Mitch WE, Du J, Bailey JL, et al: Mechanisms causing muscle proteolysis in uremia: the influence of insulin and cytokines. Miner Elect Metab 25:216-219, 1999
121. Garcia-Martinez C, Llovera M, Agell N, et al: Ubiquitin gene expression in skeletal muscle is increased by tumour necrosis factor-α. Biochem Biophys Res Commun 201:682-686, 1994
122. Goodman MN: Interleukin-6 induces skeletal muscle protein breakdown in rats. Proc Soc Exp Biol Med 205:182-185, 1994
123. Tsujinaka T, Fujita J, Ebisuri C, et al: Interleukin-6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin-6 transgenic mice. J Clin Invest 97:244-249, 1996
124. Srivastava MD, Srivastava BI, Brouhard B: Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology 40:179-185, 1998
125. Goldberg RM, Loprinzi CL, Mailliard JA, et al: Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol 13:2856-2859, 1995
126. Reyes-Terán G, Sierra-Madero JG, Martinez del Cerro V, et al: Effects of thalidomide on HIV-associated wasting syndrome: A randomized, double blind, placebo-controlled clinical study. AIDS 10: 1501-1507, 1996
127. Buck M, Chojkier M: Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J 15:1753-1765, 1996
128. Lundholm K, Gelin J, Hyltander A, et al: Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 54:5602-5606, 1994